PDI receives FDA clearance for Prevantics Device Swab

PDI introduced the Prevantics Device Swab after receiving market authorization from the U.S. Food and Drug Administration for disinfecting needleless access sites prior to use on ports and hubs.
The Chlorhexidine Gluconate/alcohol solution based swab is fully compliant with the evidence-based guidelines and recommendations from the Centers for Disease Control and Prevention, Infusion Nurses Society, Association for Vascular Access and Association for Professionals in Infection Control and Epidemiology.

PDI is a manufacturer of infection prevention products and solutions.

More articles on practice management:

4 steps to take when dealing with negative online reviews
Can you guarantee outcomes? Virginia Mason offers total joint replacement warranty
What spine surgeons stand to gain and lose from risk sharing payment models

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers

Featured Podcast